Lifestyle

Indonesia resumes use of AstraZeneca’s COVID-19 vaccine

On March 8, 2021, announced by the Indonesian presidential palace, workers will unload a container containing the AstraZeneca COVID-19 vaccine upon arrival at Soekarno Hatta International Airport in Tangerang, a suburb of Jakarta, Indonesia. On Friday, March 19, 2021, Indonesia allowed the AstraZeneca vaccine to be used again after European Union drug regulators stated that the vaccine did not increase the overall incidence of blood clots. (Indonesian Presidential Palace via AP)

Indonesia allowed the AstraZeneca vaccine to be used again on Friday after European Union drug regulators said the vaccine did not increase the overall incidence of blood clots.

Southeast Asia’s largest economy has delayed the deployment of the COVID-19 vaccine after more than 12 European countries have suspended the vaccine due to concerns of some who have received the vaccine to develop blood clots.

“The benefits of using the COVID-19 vaccine AstraZeneca outweigh the potential risks and allow us to start using it,” the Indonesian Food and Drug Administration said in a statement.

Earlier, the World Health Organization stated that there was no evidence that the vaccine was due to blood clots.

An Indonesian agency said the risk of death from COVID-19 was much higher, “therefore, the community must be vaccinated against COVID-19 according to a specified schedule.”

Indonesia received 1.1 million AstraZeneca vaccines on March 8 through COVAX (a multilateral effort to ensure fair global access to the COVID-19 vaccine).

Indonesia resumes use of AstraZeneca's COVID-19 vaccine

In this photo released by the Indonesian presidential palace, a worker arriving at Soekarno Hatta International Airport in Tangerang, a suburb of Jakarta, Indonesia, put a sticker on a container containing the AstraZeneca COVID-19 vaccine on March 8, 2021. I am. On Friday, March 19, 2021, Indonesia allowed the AstraZeneca vaccine to be used again after European Union drug regulators stated that the vaccine did not increase the overall incidence of blood clots. (Indonesian Presidential Palace via AP)

The AstraZeneca vaccine is the second vaccine to arrive in Indonesia, following the vaccine manufactured by Chinese biopharmacy company Sinovac.

Indonesia aims to inoculate more than 181 million out of 270 million people by March 2022 as part of a free vaccination drive that began in January.


Follow the latest news about the outbreak of coronavirus (COVID-19)


© 2021 AP communication. all rights reserved. This material may not be published, broadcast, rewritten, or redistributed without permission.

Quote: Indonesia obtained AstraZeneca’s COVID-19 vaccine from https://medicalxpress.com/news/2021-03-indonesia-resumes-astrazeneca-covid-vaccine.html on March 19, 2021 (3 2021) 19th of March) will resume use

This document is subject to copyright. No part may be reproduced without written permission, except for fair transactions for personal investigation or research purposes. The content is provided for informational purposes only.



Indonesia resumes use of AstraZeneca’s COVID-19 vaccine

Source link Indonesia resumes use of AstraZeneca’s COVID-19 vaccine

Show More

Related Articles

Back to top button